-
-
7 . Periodical
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
- 저자
- by Kelley, Robin Kate; Ueno, Makoto; Yoo, Changhoon; Finn, Richard S; Furuse, Junji, et al.
- 소스
- The Lancet; June 2023, Vol. 401 Issue: 10391 p1853-1865, 13p